Qing Luo

582 total citations
21 papers, 322 citations indexed

About

Qing Luo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Qing Luo has authored 21 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Qing Luo's work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Qing Luo is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Qing Luo collaborates with scholars based in China, United States and Australia. Qing Luo's co-authors include Changzhi Huang, Jialing Zhong, Dan Yang, Qian Zhao, Zhihong Liu, Zhiwei Huang, Xin Ma, Zhiyong Zhao, Weiwei Liu and Jia Wang and has published in prestigious journals such as Medicine, Signal Transduction and Targeted Therapy and Journal of Cellular Biochemistry.

In The Last Decade

Qing Luo

19 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qing Luo China 9 150 89 84 77 53 21 322
Tomoko Kitaichi Japan 7 145 1.0× 93 1.0× 46 0.5× 106 1.4× 61 1.2× 16 344
Anna P. Koh United States 7 118 0.8× 60 0.7× 32 0.4× 30 0.4× 37 0.7× 11 382
Ryo Yamashita Japan 8 120 0.8× 75 0.8× 40 0.5× 58 0.8× 71 1.3× 40 375
J. Agustin Cruz United States 8 109 0.7× 77 0.9× 26 0.3× 27 0.4× 14 0.3× 10 336
Laure Maneix United States 12 162 1.1× 48 0.5× 63 0.8× 41 0.5× 11 0.2× 24 353
Lucille N. Meliton United States 12 401 2.7× 61 0.7× 46 0.5× 157 2.0× 19 0.4× 17 539
Clément Molina France 5 171 1.1× 36 0.4× 232 2.8× 23 0.3× 25 0.5× 6 390
Clément Oyeniran United States 10 387 2.6× 57 0.6× 105 1.3× 33 0.4× 10 0.2× 12 519
Silvia Codenotti Italy 10 176 1.2× 97 1.1× 20 0.2× 108 1.4× 13 0.2× 26 298
Seira Hatakeyama Japan 7 110 0.7× 54 0.6× 129 1.5× 26 0.3× 10 0.2× 12 376

Countries citing papers authored by Qing Luo

Since Specialization
Citations

This map shows the geographic impact of Qing Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Luo more than expected).

Fields of papers citing papers by Qing Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Luo. The network helps show where Qing Luo may publish in the future.

Co-authorship network of co-authors of Qing Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Luo. A scholar is included among the top collaborators of Qing Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Luo. Qing Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Yuhui, et al.. (2025). Potential mechanism of Camellia luteoflora against colon adenocarcinoma: An integration of network pharmacology and molecular docking. World Journal of Gastrointestinal Oncology. 17(6). 105782–105782.
2.
Zhang, Hong, et al.. (2024). Tumor energy metabolism: implications for therapeutic targets. Molecular Biomedicine. 5(1). 63–63. 8 indexed citations
3.
Liang, Rui, et al.. (2024). Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. Signal Transduction and Targeted Therapy. 9(1). 340–340. 25 indexed citations
4.
Luo, Qing, et al.. (2023). High carrier frequency of pathogenic PATL2 gene mutations predicted in population: a bioinformatics-based approach. Frontiers in Genetics. 14. 1097951–1097951. 6 indexed citations
5.
Wang, Bin, Bin Liu, Qing Luo, et al.. (2022). PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database. Translational Cancer Research. 11(7). 2321–2337. 5 indexed citations
6.
Li, Xiaomei, et al.. (2022). Sinomenine hydrochloride suppresses the stemness of breast cancer stem cells by inhibiting Wnt signaling pathway through down-regulation of WNT10B. Pharmacological Research. 179. 106222–106222. 18 indexed citations
7.
Li, Feng, et al.. (2020). Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature. Bioscience Reports. 40(8). 11 indexed citations
8.
9.
Wang, Xue, et al.. (2019). Association between lncRNA H19 rs217727 polymorphism and the risk of cancer: an updated meta-analysis. BMC Medical Genetics. 20(1). 186–186. 6 indexed citations
10.
Xiong, Yuanping, et al.. (2019). Novel Bougie for the Management of Esophageal Coins in Children: An Observational Study. Annals of Otology Rhinology & Laryngology. 128(6). 503–507. 1 indexed citations
11.
12.
Lin, Zhiyuan, Hongwei Jin, Huayue Lin, et al.. (2018). Performance evaluation of a chemiluminescence microparticle immunoassay for CK‐MB. Journal of Clinical Laboratory Analysis. 32(6). e22426–e22426. 4 indexed citations
13.
Luo, Qing, et al.. (2018). PREVALENCE OF THE MAIN FORMS OF LOW RENIN HYPERTENSION. Journal of Hypertension. 36(Supplement 1). e133–e133.
14.
Luo, Qing, et al.. (2018). Clinicopathological and prognostic significance of zinc finger antisense 1 overexpression in cancers. Medicine. 97(49). e13378–e13378. 1 indexed citations
15.
16.
Lin, Huayue, Zanxi Fang, Peihua Li, et al.. (2017). DHX32 Promotes Angiogenesis in Colorectal Cancer Through Augmenting β-catenin Signaling to Induce Expression of VEGFA. EBioMedicine. 18. 62–72. 21 indexed citations
17.
18.
Yang, Mei, Yuyu Gu, Hua Peng, et al.. (2014). NAIF1 inhibits gastric cancer cells migration and invasion via the MAPK pathways. Journal of Cancer Research and Clinical Oncology. 141(6). 1037–1047. 23 indexed citations
19.
Ma, Yiming, Mei Zhao, Jialing Zhong, et al.. (2010). Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer. Journal of Cellular Biochemistry. 110(6). 1512–1519. 46 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoko Kitaichi Breakdown of academic impact, for papers by Anna P. Koh Breakdown of academic impact, for papers by Ryo Yamashita Breakdown of academic impact, for papers by J. Agustin Cruz Breakdown of academic impact, for papers by Laure Maneix Breakdown of academic impact, for papers by Lucille N. Meliton Breakdown of academic impact, for papers by Clément Molina Breakdown of academic impact, for papers by Clément Oyeniran Breakdown of academic impact, for papers by Silvia Codenotti Breakdown of academic impact, for papers by Seira Hatakeyama
Rankless by CCL
2026